EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine

Jacqueline D Silva, Giulio Taglialatela, Daniel C Jupiter

Journal of Alzheimer's Disease · 2023

DOI: 10.3233/jad-230526 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Alzheimer's Disease, 2023. Verfasst von Jacqueline D Silva und 2 weiteren Autor:innen. Beteiligte Einrichtung: Mitchell Center for Neurodegenerative Disorders, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA. Hauptthemen laut MEDLINE: Kidney Transplantation, Dementia. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCATS NIH HHS, NIA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Evidence suggests patients prescribed calcineurin inhibitors (CNIs) have a reduced prevalence of dementia, including Alzheimer’s disease (AD); however, this result has never been replicated in a large cohort and the involved mechanism(s) and site of action (central versus periphery) remain unclear.

Objective

We aim to determine if prescription of CNIs is associated with reduced prevalence of dementia, including AD, in a large, diverse patient population. Furthermore, we aim to gain insight into the mechanism(s) and site of action for CNIs to reduce dementia prevalence.

Methods

Electronic health records (EHRs) from patients prescribed tacrolimus, cyclosporine, or sirolimus were analyzed to compare prevalence, odds, and hazard ratios related to dementia diagnoses among cohorts. EHRs from a random, heterogeneous population from the same network were obtained to generate a general population-like control.

Results

All drugs examined reduced dementia prevalence compared to the general population-like control. There were no differences in dementia diagnoses upon comparing tacrolimus and sirolimus; however, patients prescribed tacrolimus had a reduced dementia prevalence relative to cyclosporine.

Conclusion

Converging mechanisms of action between tacrolimus and sirolimus likely explain the similar dementia prevalence between the cohorts. Calcineurin inhibition within the brain has a greater probability of reducing dementia relative to peripherally-restricted calcineurin inhibition. Overall, immunosuppressants provide a promising therapeutic avenue for dementia, with emphasis on the brain-penetrant CNI tacrolimus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationDementiaHumansCyclosporineTacrolimusSirolimusCalcineurinPrevalenceCalcineurin Inhibitors

Stichwörter der Autor:innen

Alzheimer’s diseaseTriNetXcalcineurincyclosporinedementia prevalencedrug repurposingelectronic health recordssirolimustacrolimus

Substanzen

CyclosporineTacrolimusSirolimusCalcineurinCalcineurin Inhibitors

Autor:innen und Institutionen

  • Mitchell Center for Neurodegenerative Disorders, Department of Neurology, University of Texas Medical Branch, Galveston, TX, USA.
  • Pharmacology and Toxicology Graduate Program, University of Texas Medical Branch, Galveston, TX, USA.
  • Department of Biostatistics and Data Science, University of Texas Medical Branch, Galveston, TX, USA.
  • Department of Orthopedics and Rehabilitation, University of Texas Medical Branch, Galveston, TX, USA.

Förderung

  • NCATS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Silva, J. D., Taglialatela, G., & Jupiter, D. C. (2023). Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine. Journal of Alzheimer's Disease. https://doi.org/10.3233/jad-230526

Vancouver

Silva JD, Taglialatela G, Jupiter DC. Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine. Journal of Alzheimer's Disease. 2023. doi:10.3233/jad-230526

BibTeX
@article{Silva2023,
  author = {Silva, Jacqueline D and Taglialatela, Giulio and Jupiter, Daniel C},
  title = {Reduced Prevalence of Dementia in Patients Prescribed Tacrolimus, Sirolimus, or Cyclosporine},
  journal = {Journal of Alzheimer's Disease},
  year = {2023},
  doi = {10.3233/jad-230526}
}
Kostenlos starten →